Clinical Research Directory
Browse clinical research sites, groups, and studies.
Continued Access Study for Participants Deriving Benefit in Pfizer-Sponsored Avelumab Parent Studies That Are Closing
Sponsor: Pfizer
Summary
This Master Protocol for Avelumab Continuation Sub-Studies is to provide continued treatment access, safety follow-up, and when applicable, overall survival follow-up for eligible participants who continue to derive a benefit from study intervention in the Pfizer-sponsored Avelumab parent studies.
Official title: Avelumab Master Protocol: An Open-label Continuation Study for Participants Continuing From Pfizer-sponsored Avelumab Clinical Studies.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
68
Start Date
2021-09-29
Completion Date
2026-09-30
Last Updated
2025-06-25
Healthy Volunteers
No
Interventions
Avelumab
oral
Lorlatanib
oral
Talazoparib
oral
Pemetrexed
IV (intravenous) infusion
Axitinib
oral
CMP 001
IT (intratumoral) or SC (subcutaneous)
Utomilumab
IV infusion
PF04518600
IV infusion
Locations (68)
Highlands Oncology Group, PA
Fayetteville, Arkansas, United States
Highlands Oncology Group, PA
Rogers, Arkansas, United States
Highlands Oncology Group, PA
Springdale, Arkansas, United States
UCLA Hematology/Oncology
Los Angeles, California, United States
Moffitt Cancer Center
Tampa, Florida, United States
MSK Basking Ridge
Basking Ridge, New Jersey, United States
MSK Monmouth
Middletown, New Jersey, United States
MSK Bergen
Montvale, New Jersey, United States
MSK Commack
Commack, New York, United States
MSK Westchester
Harrison, New York, United States
Memorial Sloan Kettering Cancer Center - David H. Koch Center for Cancer Care (74th Street).
New York, New York, United States
Memorial Sloan Kettering Cancer Center 53rd street.
New York, New York, United States
Memorial Sloan Kettering Cancer Center
New York, New York, United States
MSK Nassau
Uniondale, New York, United States
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, United States
The University of Texas MD Anderson Cancer Center
Houston, Texas, United States
Fred Hutchinson Cancer Center
Seattle, Washington, United States
Macquarie University
North Ryde, New South Wales, Australia
Mater Hospital Sydney
Wollstonecraft, New South Wales, Australia
Melanoma Institute Australia
Wollstonecraft, New South Wales, Australia
The Prince Charles Hospital
Chermside, Queensland, Australia
Grand Hôpital de Charleroi
Gilly, Hainaut, Belgium
UZ Gent
Ghent, Oost-vlaanderen, Belgium
Cross Cancer Institute
Edmonton, Alberta, Canada
Kingston Health Sciences Centre-Kingston General Hospital Site
Kingston, Ontario, Canada
Aalborg Universitetshospital, Syd
Aalborg, North Denmark, Denmark
Institut de Cancérologie de Lorraine Alexis Vautrin
Vandœuvre-lès-Nancy, Lorraine, France
Országos Onkológiai Intézet
Budapest, Hungary
Rabin Medical Center
Petah Tikva, Central District, Israel
Fondazione IRCCS Istituto Nazionale dei Tumori
Milan, Lombardy, Italy
Fondazione IRCCS Istituto Nazionale dei Tumori
Milan, Milano, Italy
IRCCS Istituto Clinico Humanitas
Rozzano, Milano, Italy
Azienda Ospedaliero Universitaria Ospedali Riuniti Umberto I - G.M. Lancisi - G. Salesi
Ancona, Italy
Oita University Hospital
Yufu, Oita Prefecture, Japan
National Cancer Center Hospital
Chuo-ku, Tokyo, Japan
Japanese Foundation for Cancer Research
Koto, Tokyo, Japan
National Hospital Organization Kyushu Cancer Center
Fukuoka, Japan
Hospital Universitario "Dr. Jose Eleuterio Gonzalez"
Monterrey, Nuevo León, Mexico
Oaxaca Site Management Organization S.C.
Oaxaca City, Mexico
Auckland City Hospital
Auckland, New Zealand
Centralny Szpital Kliniczny MSWiA w Warszawie
Warsaw, Poland
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy w Warszawie
Warsaw, Poland
Budgetary Healthcare Institution of Omsk Region "Clinical Oncology Dispensary"
Omsk, Omsk Oblast, Russia
Private Medical Institution "Euromedservice"
Pushkin, Sankt-Peterburg, Russia
GBUZ SK Pyatigorsk Interdistrict Oncology dispensary
Pyatigorsk, Stavropol Kray, Russia
Moscow Scientific Research Oncology Institute n.a. P.A. Hertzen
Moscow, Russia
FBIH "Privolzhskiy Regional Medical Center" of FMBA
Nizhny Novgorod, Russia
SAHI Republican Clinical Oncology Dispensary under the Ministry of Health, Republic of Bashkortostan
Ufa, Russia
Institute for Oncology and Radiology of Serbia
Belgrade, Serbia
Gachon University Gil Medical Center
Namdong-gu, Incheon-gwangyeoksi [incheon], South Korea
National Cancer Center
Goyang-si, Kyǒnggi-do, South Korea
Seoul National University Bundang Hospital
Seongnam, Kyǒnggi-do, South Korea
Seoul National University Hospital
Seoul, Seoul-teukbyeolsi [seoul], South Korea
Asan Medical Center
Seoul, Seoul-teukbyeolsi [seoul], South Korea
Samsung Medical Center
Seoul, Seoul-teukbyeolsi [seoul], South Korea
Hospital Universitari Vall d'Hebron
Barcelona, Barcelona [barcelona], Spain
Hospital Clínic de Barcelona
Barcelona, Barcelona [barcelona], Spain
Institut Català d'Oncologia - L'Hospitalet
L'Hospitalet de Llobregat, Barcelona, Spain
Hospital Universitari Vall d'Hebron
Barcelona, Spain
Hospital Universitario Fundación Jiménez Díaz
Madrid, Spain
Hospital Universitario HM Sanchinarro
Madrid, Spain
Hospital Universitario Virgen de Valme
Seville, Spain
National Cheng Kung University Hospital
Tainan, Taiwan
National Taiwan University Hospital
Taipei, Taiwan
Chang Gung Medical Foundation-Linkou Branch
Taoyuan District, Taiwan
Royal Marsden Hospital (Chelsea)
London, Kensington and Chelsea, United Kingdom
The Newcastle Upon Tyne Hospitals NHS Foundation Trust
Newcastle upon Tyne, United Kingdom
Royal Cornwall Hospitals NHS Trust
Truro, United Kingdom